DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes
A genetic predisposition to higher waist-to-hip ratio adjusted for BMI (WHRadjBMI), a measure of body fat distribution, associates with increased risk for type 2 diabetes. We conducted an exome-wide association study of coding variation in UK Biobank (405,569 individuals) to identify variants that l...
| Váldodahkkit: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
American Diabetes Association
2018
|
| _version_ | 1826257538471952384 |
|---|---|
| author | Emdin, C Khera, A Aragam, K Haas, M Chaffin, M Klarin, D Natarajan, P Bick, A Zekavat, S Nomura, A Ardissino, D Wilson, J Schunkert, H McPherson, R Watkins, H Elosua, R Bown, M Samani, N Baber, U Erdmann, J Gupta, N Danesh, J Saleheen, D Gabriel, S Kathiresan, S |
| author_facet | Emdin, C Khera, A Aragam, K Haas, M Chaffin, M Klarin, D Natarajan, P Bick, A Zekavat, S Nomura, A Ardissino, D Wilson, J Schunkert, H McPherson, R Watkins, H Elosua, R Bown, M Samani, N Baber, U Erdmann, J Gupta, N Danesh, J Saleheen, D Gabriel, S Kathiresan, S |
| author_sort | Emdin, C |
| collection | OXFORD |
| description | A genetic predisposition to higher waist-to-hip ratio adjusted for BMI (WHRadjBMI), a measure of body fat distribution, associates with increased risk for type 2 diabetes. We conducted an exome-wide association study of coding variation in UK Biobank (405,569 individuals) to identify variants that lower WHRadjBMI and protect against type 2 diabetes. We identified four variants in the gene ACVR1C (encoding the activin receptor-like kinase 7 receptor expressed on adipocytes and pancreatic β-cells), which independently associated with reduced WHRadjBMI: Asn150His (−0.09 SD, P = 3.4 × 10−17), Ile195Thr (−0.15 SD, P = 1.0 × 10−9), Ile482Val (−0.019 SD, P = 1.6 × 10−5), and rs72927479 (−0.035 SD, P = 2.6 × 10−12). Carriers of these variants exhibited reduced percent abdominal fat in DEXA imaging. Pooling across all four variants, a 0.2 SD decrease in WHRadjBMI through ACVR1C was associated with a 30% lower risk of type 2 diabetes (odds ratio [OR] 0.70, 95% CI 0.63, 0.77; P = 5.6 × 10−13). In an analysis of exome sequences from 55,516 individuals, carriers of predicted damaging variants in ACVR1C were at 54% lower risk of type 2 diabetes (OR 0.46, 95% CI 0.27, 0.81; P = 0.006). These findings indicate that variants predicted to lead to loss of ACVR1C gene function influence body fat distribution and protect from type 2 diabetes. |
| first_indexed | 2024-03-06T18:19:48Z |
| format | Journal article |
| id | oxford-uuid:05e2203d-942c-4ba7-9c16-43c2a68d6a84 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:19:48Z |
| publishDate | 2018 |
| publisher | American Diabetes Association |
| record_format | dspace |
| spelling | oxford-uuid:05e2203d-942c-4ba7-9c16-43c2a68d6a842022-03-26T08:59:40ZDNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:05e2203d-942c-4ba7-9c16-43c2a68d6a84EnglishSymplectic Elements at OxfordAmerican Diabetes Association2018Emdin, CKhera, AAragam, KHaas, MChaffin, MKlarin, DNatarajan, PBick, AZekavat, SNomura, AArdissino, DWilson, JSchunkert, HMcPherson, RWatkins, HElosua, RBown, MSamani, NBaber, UErdmann, JGupta, NDanesh, JSaleheen, DGabriel, SKathiresan, SA genetic predisposition to higher waist-to-hip ratio adjusted for BMI (WHRadjBMI), a measure of body fat distribution, associates with increased risk for type 2 diabetes. We conducted an exome-wide association study of coding variation in UK Biobank (405,569 individuals) to identify variants that lower WHRadjBMI and protect against type 2 diabetes. We identified four variants in the gene ACVR1C (encoding the activin receptor-like kinase 7 receptor expressed on adipocytes and pancreatic β-cells), which independently associated with reduced WHRadjBMI: Asn150His (−0.09 SD, P = 3.4 × 10−17), Ile195Thr (−0.15 SD, P = 1.0 × 10−9), Ile482Val (−0.019 SD, P = 1.6 × 10−5), and rs72927479 (−0.035 SD, P = 2.6 × 10−12). Carriers of these variants exhibited reduced percent abdominal fat in DEXA imaging. Pooling across all four variants, a 0.2 SD decrease in WHRadjBMI through ACVR1C was associated with a 30% lower risk of type 2 diabetes (odds ratio [OR] 0.70, 95% CI 0.63, 0.77; P = 5.6 × 10−13). In an analysis of exome sequences from 55,516 individuals, carriers of predicted damaging variants in ACVR1C were at 54% lower risk of type 2 diabetes (OR 0.46, 95% CI 0.27, 0.81; P = 0.006). These findings indicate that variants predicted to lead to loss of ACVR1C gene function influence body fat distribution and protect from type 2 diabetes. |
| spellingShingle | Emdin, C Khera, A Aragam, K Haas, M Chaffin, M Klarin, D Natarajan, P Bick, A Zekavat, S Nomura, A Ardissino, D Wilson, J Schunkert, H McPherson, R Watkins, H Elosua, R Bown, M Samani, N Baber, U Erdmann, J Gupta, N Danesh, J Saleheen, D Gabriel, S Kathiresan, S DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title | DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title_full | DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title_fullStr | DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title_full_unstemmed | DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title_short | DNA sequence variation in ACVR1C encoding the activin receptor-like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| title_sort | dna sequence variation in acvr1c encoding the activin receptor like kinase 7 influences body fat distribution and protects against type 2 diabetes |
| work_keys_str_mv | AT emdinc dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT kheraa dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT aragamk dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT haasm dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT chaffinm dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT klarind dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT natarajanp dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT bicka dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT zekavats dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT nomuraa dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT ardissinod dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT wilsonj dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT schunkerth dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT mcphersonr dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT watkinsh dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT elosuar dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT bownm dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT samanin dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT baberu dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT erdmannj dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT guptan dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT daneshj dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT saleheend dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT gabriels dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes AT kathiresans dnasequencevariationinacvr1cencodingtheactivinreceptorlikekinase7influencesbodyfatdistributionandprotectsagainsttype2diabetes |